Cite
APA Citation
Reardon, D., Kaley, T., Iwamoto, F., Baehring, J., Subramaniam, D., Rawls, T., He, Y., Keler, T., & Yellin, M. (n.d.). aTIM-23. ANTI-CD27 AGONIST ANTIBODY VARLILUMAB IN COMBINATION WITH NIVOLUMAB FOR RECURRENT GLIOBLASTOMA (rGBM): PHASE 2 CLINICAL TRIAL RESULTS. Neuro-oncology, 20, vi6. http://access.bl.uk/ark:/81055/vdc_100095515730.0x000018